SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Shasun gets nod for demerger plan with Sequent Scientific

22 Mar 2017 Evaluate

Strides Shasun’s board of directors on the recommendation of audit committee has approved the composite scheme of arrangement with Sequent Scientific and SSL Pharma Sciences. Through this scheme, the commodity API business of Strides and human API business of Sequent Scientific will be demerged to SSL Pharma Sciences, a wholly-owned subsidiary of Strides, by October 1.

With the demerger, shareholders of Strides and Sequent Scientific will hold 60 per cent and 40 per cent, respectively. The capital base for the new entity will be Rs 25 crore as opposed to the current capital base of Rs 89.42 crore of Strides and Rs 48.75 crore of Sequent Scientific. Every shareholder of Strides will get one equity share of Rs 10 each of SSL Pharma Sciences for every six equity share of Rs 10 each held by them in Strides.

Strides Shasun (formerly known as Strides Arcolab) is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

 

Strides Pharma Scien Share Price

1081.80 7.95 (0.74%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: